Regulation of tumor angiogenesis by EZH2. (Q34073170)

30 July 2017

Regulation of tumor angiogenesis by EZH2. (English)

1 reference

30 July 2017

1 reference

1 reference

30

George A Calin

1 reference

30 July 2017

36

Mien-Chie Hung

1 reference

30 July 2017

38

Anil K Sood

1 reference

30 July 2017

Gabriel Lopez-Berestein

37

object named as

Gabriel Lopez-Berestein

1 reference

30 July 2017

Chunhua Lu

1

1 reference

30 July 2017

Hee Dong Han

2

1 reference

30 July 2017

Lingegowda S Mangala

3

1 reference

30 July 2017

Rouba Ali-Fehmi

4

1 reference

30 July 2017

Christopher S Newton

5

1 reference

30 July 2017

Laurent Ozbun

6

1 reference

30 July 2017

Guillermo N Armaiz-Pena

7

1 reference

30 July 2017

Wei Hu

8

1 reference

30 July 2017

Rebecca L Stone

9

1 reference

30 July 2017

Adnan Munkarah

10

1 reference

30 July 2017

Murali K Ravoori

11

1 reference

30 July 2017

Mian M K Shahzad

12

1 reference

30 July 2017

Jeong-Won Lee

13

1 reference

30 July 2017

Edna Mora

14

1 reference

30 July 2017

Robert R Langley

15

1 reference

30 July 2017

Amy R Carroll

16

1 reference

30 July 2017

Koji Matsuo

17

1 reference

30 July 2017

Whitney A Spannuth

18

1 reference

30 July 2017

Rosemarie Schmandt

19

1 reference

30 July 2017

Nicholas B Jennings

20

1 reference

30 July 2017

Blake W Goodman

21

1 reference

30 July 2017

Robert B Jaffe

22

1 reference

30 July 2017

Alpa M Nick

23

1 reference

30 July 2017

Hye Sun Kim

24

1 reference

30 July 2017

Eylem Ozturk Guven

25

1 reference

30 July 2017

Ya-Huey Chen

26

1 reference

30 July 2017

Long-Yuan Li

27

1 reference

30 July 2017

Ming-Chuan Hsu

28

1 reference

30 July 2017

Robert L Coleman

29

1 reference

30 July 2017

Emir B Denkbas

31

1 reference

30 July 2017

Jae Yun Lim

32

1 reference

30 July 2017

Ju-Seog Lee

33

1 reference

30 July 2017

Vikas Kundra

34

1 reference

30 July 2017

Michael J Birrer

35

1 reference

30 July 2017

1 August 2010

1 reference

30 July 2017

1 reference

30 July 2017

18

1 reference

30 July 2017

185-197

1 reference

30 July 2017

2

1 reference

Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Connective tissue growth factor: context-dependent functions and mechanisms of regulation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Dicer, Drosha, and outcomes in patients with ovarian cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Functional significance of VEGFR-2 on ovarian cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Connective tissue growth factor (CTGF) and cancer progression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Impact of vessel maturation on antiangiogenic therapy in ovarian cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Angiogenesis as a strategic target for ovarian cancer therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

DNA methylation and complete transcriptional silencing of cancer genes persist after depletion of EZH2.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Lessons from phase III clinical trials on anti-VEGF therapy for cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

The polycomb group protein EZH2 is involved in progression of prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human p

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Repression and activation by multiprotein complexes that alter chromatin structure

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Locking in stable states of gene expression: transcriptional control during Drosophila development.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

What Is the Evidence That Tumors Are Angiogenesis Dependent?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Vascular endothelial growth factor promotes proliferation of cortical neuron precursors by regulating E2F expression

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Molecular and physiologic mechanisms of drug resistance in cancer: an overview.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Chromo-domain proteins: linking chromatin structure to epigenetic regulation.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2923653

Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways

28 October 2018

1 reference

12 December 2020

Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies

1 reference

12 December 2020

Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival

1 reference

12 December 2020

Nitric oxide activation of peroxisome proliferator-activated receptor gamma through a p38 MAPK signaling pathway

1 reference

12 December 2020

10.1016/J.CCR.2010.06.016

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference